• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟奥密克戎及新出现的变异株对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播和公共卫生负担的影响。

Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden.

作者信息

Le Rutte Epke A, Shattock Andrew J, Chitnis Nakul, Kelly Sherrie L, Penny Melissa A

机构信息

Swiss Tropical and Public Health Institute, Allschwil, Switzerland.

University of Basel, Basel, Switzerland.

出版信息

Commun Med (Lond). 2022 Jul 25;2:93. doi: 10.1038/s43856-022-00154-z. eCollection 2022.

DOI:10.1038/s43856-022-00154-z
PMID:35899148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9311342/
Abstract

BACKGROUND

SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessing the impact of their potential viral properties on the probability of future transmission dominance and public health burden is fundamental in guiding ongoing COVID-19 control strategies.

METHODS

With an individual-based transmission model, OpenCOVID, we simulated three viral properties; infectivity, severity, and immune-evading ability, all relative to the Delta variant, to identify thresholds for Omicron's or any emerging VOC's potential future dominance, impact on public health, and risk to health systems. We further identify for which combinations of viral properties current interventions would be sufficient to control transmission.

RESULTS

We show that, with first-generation SARS-CoV-2 vaccines and limited physical distancing in place, a VOC's potential future dominance is primarily driven by its infectivity, which does not always lead to an increased public health burden. However, we also show that highly immune-evading variants that become dominant, even in the case of reduced variant severity, would likely require alternative measures to avoid strain on health systems, such as strengthened physical distancing measures, novel treatments, and second-generation vaccines. Expanded vaccination, that includes a booster dose for adults and child vaccination strategies, is projected to have the biggest public health benefit for a highly infective, highly severe VOC with low immune-evading capacity.

CONCLUSIONS

These findings provide quantitative guidance to decision-makers at a critical time while Omicron's properties are being assessed and preparedness for emerging VOCs is eminent. We emphasise the importance of both genomic and population epidemiological surveillance.

摘要

背景

值得关注的新冠病毒变异株,如奥密克戎(B.1.1.529),仍在不断出现。评估其潜在病毒特性对未来传播优势概率和公共卫生负担的影响,对于指导当前的新冠疫情防控策略至关重要。

方法

我们使用基于个体的传播模型OpenCOVID,模拟了三种病毒特性;传染性、严重性和免疫逃逸能力,所有这些均相对于德尔塔变异株,以确定奥密克戎或任何新出现的变异株未来潜在优势、对公共卫生的影响以及对卫生系统的风险阈值。我们还确定了对于哪些病毒特性组合,当前的干预措施足以控制传播。

结果

我们表明,在第一代新冠疫苗接种且保持有限的物理距离措施的情况下,一种变异株未来的潜在优势主要由其传染性驱动,而这并不总是导致公共卫生负担增加。然而,我们也表明,即使变异株严重性降低,但成为优势毒株的高免疫逃逸变异株可能需要采取替代措施以避免给卫生系统造成压力,如加强物理距离措施、新型治疗方法和第二代疫苗。预计扩大疫苗接种,包括为成年人接种加强针以及儿童疫苗接种策略,对于具有高传染性、高严重性且低免疫逃逸能力的变异株将带来最大的公共卫生益处。

结论

在评估奥密克戎特性以及为新出现的变异株做好准备的关键时期,这些发现为决策者提供了定量指导。我们强调基因组监测和人群流行病学监测的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f275/9314323/0fa763c8f74c/43856_2022_154_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f275/9314323/a92688d96ab2/43856_2022_154_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f275/9314323/4045c6091e53/43856_2022_154_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f275/9314323/0fa763c8f74c/43856_2022_154_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f275/9314323/a92688d96ab2/43856_2022_154_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f275/9314323/4045c6091e53/43856_2022_154_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f275/9314323/0fa763c8f74c/43856_2022_154_Fig3_HTML.jpg

相似文献

1
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden.模拟奥密克戎及新出现的变异株对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播和公共卫生负担的影响。
Commun Med (Lond). 2022 Jul 25;2:93. doi: 10.1038/s43856-022-00154-z. eCollection 2022.
2
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株德尔塔迅速被奥密克戎取代:新冠病毒疾病病例数出现前所未有的激增,住院人数减少,上呼吸道病毒载量相当。
medRxiv. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927.
3
SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis.严重急性呼吸综合征冠状病毒2型奥密克戎变异株基因组序列及其与大流行结束相关的流行病学关联:计算机模拟分析
JMIR Bioinform Biotechnol. 2023 Jan 10;4:e42700. doi: 10.2196/42700. eCollection 2023.
4
COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups.鉴于新出现的病毒变种的新冠疫苗加强针策略:频率、时机和目标群体
Infect Dis Ther. 2022 Oct;11(5):2045-2061. doi: 10.1007/s40121-022-00683-z. Epub 2022 Sep 12.
5
Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.美国亚利桑那州公共临床检测、医院和社区污水的基线测序监测显示,SARS-CoV-2 关注的奥密克戎变异株迅速出现。
mBio. 2023 Feb 28;14(1):e0310122. doi: 10.1128/mbio.03101-22. Epub 2023 Jan 9.
6
The Evolution and Biology of SARS-CoV-2 Variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的进化与生物学
Cold Spring Harb Perspect Med. 2022 May 27;12(5):a041390. doi: 10.1101/cshperspect.a041390.
7
Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types.模拟 SARS-CoV-2 Delta 和 Omicron 变异株在不同细胞类型中的病毒动力学。
J R Soc Interface. 2023 Aug;20(205):20230187. doi: 10.1098/rsif.2023.0187. Epub 2023 Aug 9.
8
New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.利用输入病例数据进行新型 SARS-CoV-2 变异株社区获得性暴发预警的新监测指标:贝叶斯马尔可夫链蒙特卡罗方法。
JMIR Public Health Surveill. 2022 Nov 25;8(11):e40866. doi: 10.2196/40866.
9
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.接种加强针后感染 SARS-CoV-2:一项前瞻性、基于社区的病例对照研究中的疾病和症状特征。
J Infect. 2023 Dec;87(6):506-515. doi: 10.1016/j.jinf.2023.08.009. Epub 2023 Sep 28.
10
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.瑞士一项多中心队列研究:根据德尔塔和奥密克戎变异株流行期间的基线免疫状态和加强针接种情况,评估卫生专业人员感染 COVID-19 的风险和症状。
PLoS Med. 2022 Nov 7;19(11):e1004125. doi: 10.1371/journal.pmed.1004125. eCollection 2022 Nov.

引用本文的文献

1
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections.接种疫苗后感染后的循环中和抗体与SARS-CoV-2变体复制
JCI Insight. 2025 Mar 10;10(5):e185953. doi: 10.1172/jci.insight.185953.
2
Planning and adjusting the COVID-19 booster vaccination campaign to reduce disease burden.规划和调整新冠病毒加强针接种活动以减轻疾病负担。
Infect Dis Model. 2024 Sep 12;10(1):150-162. doi: 10.1016/j.idm.2024.09.002. eCollection 2025 Mar.
3
Intervention effect of targeted workplace closures may be approximated by single-layered networks in an individual-based model of COVID-19 control.

本文引用的文献

1
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance.奥密克戎变异株(B.1.1.529):传染性、疫苗突破和抗体耐药性。
J Chem Inf Model. 2022 Jan 24;62(2):412-422. doi: 10.1021/acs.jcim.1c01451. Epub 2022 Jan 6.
2
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.两剂 ChAdOx1 nCoV-19 疫苗对 COVID-19 住院和死亡的保护作用随时间变化的回顾性、基于人群的队列研究:苏格兰和巴西的研究。
Lancet. 2022 Jan 1;399(10319):25-35. doi: 10.1016/S0140-6736(21)02754-9. Epub 2021 Dec 20.
3
基于个体的 COVID-19 控制模型中,靶向工作场所关闭的干预效果可以通过单层网络来近似。
Sci Rep. 2024 Jul 26;14(1):17202. doi: 10.1038/s41598-024-66741-3.
4
Efficacy thresholds and target populations for antiviral COVID-19 treatments to save lives and costs: a modelling study.新冠病毒抗病毒治疗挽救生命和节省成本的疗效阈值及目标人群:一项建模研究
EClinicalMedicine. 2024 Jun 21;73:102683. doi: 10.1016/j.eclinm.2024.102683. eCollection 2024 Jul.
5
Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects.接种疫苗影响下的新冠病毒奥密克戎毒株浪潮的数学建模
Computation (Basel). 2023 Feb;11(2). doi: 10.3390/computation11020036. Epub 2023 Feb 15.
6
Revisiting the complex time-varying effect of non-pharmaceutical interventions on COVID-19 transmission in the United States.重新探讨非药物干预措施对美国 COVID-19 传播的复杂时变影响。
Front Public Health. 2024 Feb 21;12:1343950. doi: 10.3389/fpubh.2024.1343950. eCollection 2024.
7
Within-host evolution of SARS-CoV-2: how often are mutations transmitted from symptomatic infections?严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的宿主内进化:有症状感染中产生的突变传播频率如何?
Virus Evol. 2024 Feb 21;10(1):veae006. doi: 10.1093/ve/veae006. eCollection 2024.
8
COVID-19 passenger screening to reduce travel risk and translocation of disease.新冠病毒肺炎旅客筛查以降低旅行风险和疾病传播。
Epidemiol Infect. 2024 Feb 8;152:e36. doi: 10.1017/S0950268824000220.
9
Impact of Vaccination and Nonpharmaceutical Interventions With Possible COVID-19 Viral Evolutions Using an Agent-Based Simulation.基于主体模拟的疫苗接种和非药物干预对可能的新冠病毒进化的影响
AJPM Focus. 2023 Oct 10;3(1):100155. doi: 10.1016/j.focus.2023.100155. eCollection 2024 Feb.
10
Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study.长期疫苗接种策略以减轻 SARS-CoV-2 传播的影响:建模研究。
PLoS Med. 2023 Nov 28;20(11):e1004195. doi: 10.1371/journal.pmed.1004195. eCollection 2023 Nov.
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.
接种疫苗和非药物干预措施对瑞士 SARS-CoV-2 动力学的影响。
Epidemics. 2022 Mar;38:100535. doi: 10.1016/j.epidem.2021.100535. Epub 2021 Dec 14.
4
Omicron likely to weaken COVID vaccine protection.奥密克戎可能会削弱新冠疫苗的保护作用。
Nature. 2021 Dec;600(7889):367-368. doi: 10.1038/d41586-021-03672-3.
5
Covid-19: South Africa's surge in cases deepens alarm over omicron variant.新冠疫情:南非病例激增加深了对奥密克戎变种的担忧。
BMJ. 2021 Dec 3;375:n3013. doi: 10.1136/bmj.n3013.
6
Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear.新冠疫情:科学家担心,奥密克戎毒株可能比其他变种更具传播性,且对现有疫苗有部分抗性。
BMJ. 2021 Nov 29;375:n2943. doi: 10.1136/bmj.n2943.
7
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
8
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.德尔塔变异株对英国新冠病毒载量及针对新型严重急性呼吸综合征冠状病毒2感染的疫苗效力的影响。
Nat Med. 2021 Dec;27(12):2127-2135. doi: 10.1038/s41591-021-01548-7. Epub 2021 Oct 14.
9
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe.了解欧洲政府干预措施对 COVID-19 反弹的效果。
Nat Commun. 2021 Oct 5;12(1):5820. doi: 10.1038/s41467-021-26013-4.
10
Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada.评估新型 SARS-CoV-2 变种的相对毒力:加拿大安大略省的回顾性队列研究。
CMAJ. 2021 Oct 25;193(42):E1619-E1625. doi: 10.1503/cmaj.211248. Epub 2021 Oct 4.